Life Saving Medical Device Company For Major Heart

New York, NY
New York County


Asking Price: Annual Revenue:
$20,000,000 $169,210

Services: Medical, Dental


Request More Information
Contact the Seller

RE: Life Saving Medical Device Company For Major Heart Broker: Rick Carlson
License #: 01820673
Owner Financing is Available!
If the price and deal structure is right.

Quick Facts

Asking Price: $20,000,000
Annual Revenue: $169,210
Net Profit: Not Disclosed
Cash Flow: $31,405
Total Debt: Not Disclosed
FF&E: Not Disclosed
Real Estate: Not Disclosed
Year Established: 1998
Employees: 1
BBN Listing #: 143527574
Broker Reference #: 1029 Device

Email or Print Listing

Request More Information
Contact the Seller


Business Overview:

Our client is offering the sale of the patent and rights and current royalties stream of income to a lifesaving, ready to use device which lowers mortality, stroke risk and other risk factors in Transcatheter Aortic Valve Implantation (TAVI) or transcatheter aortic valve replacement (TAVR) procedures.

The patented device available for rights and royalties stream revenue purchase can simply be added to existent equipment to immediately improve patient outcomes. It was developed by a renowned M.D. and professor, a prolific inventor who owns more than 20 issued US and tens of International Patents and a similar number of pending patents.

According to the developer “The vision of our Project (was) to significantly improve the safety of TAVI/TAVR. Integrating or adding-on an active double-filtering, emboli capturing, collecting and removal component to the TAVI/TAVR procedure is a breakthrough. With our approach, we are bringing a better solution than the currently used deflective anti-embolic devices for preventing cerebral embolic complications. “As such, our device can be developed in 3 versions:

• Integrated to the existing delivery system
• As an add-on to an existing delivery system (generic – to fit all delivery systems)
• Independent system, inserted contra-laterally to the TAVI/TAVR delivery system
(Our client) think(s) that by avoiding secondary procedures as much as possible and by adding better filtering, entrapping, and removing embolic material as with (our client’s) device, not only “silent strokes” but other “silent vascular complications” also can be prevented. (Our client) believe(s) that the use of intra-procedural emboli protection is the best approach to reduce intra- and post-procedural embolic complications”.

NDA is required to secure comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.

To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button and when you are done searching and have made all your selections, simply click on the REQUEST INFO button at the bottom of the page.

Property Features and Assets:

N/A – Relocatable worldwide.

Market Competition and Expansion:

Growth & Expansion: Our client tells us that “The number of TAVI/TAVR procedures all over the world has increased exponentially in recent years. About 75,000 Aortic Valve Replacements are performed annually worldwide. (TAVIinformation.com) The current number of patients eligible for TAVI/TAVR procedures is approximately 350.000 worldwide, a number that is expected to grow considerably in the future.”

Reason for Selling:

Other business interests.

Additional Details:

  • The property is owned.
  • The owner is willing to train/assist the new owner.
  • This is not a homebased business opportunity.
  • This is not a franchise resale opportunity.

Relevant Links:

Request More Information
Contact the Seller



BusinessBroker.net is one of the largest business for sale marketplaces in the world that connects tens-of-thousands of business buyers and sellers every month. Sell a Business Online or if you’re a broker or a commercial agent sign up for a Business Broker Membership today!